Regenerative Medical Technology Group Inc. (RMTG)

OTCMKTS · Delayed Price · Currency is USD
0.0286
-0.0007 (-2.39%)
At close: Mar 9, 2026
-41.15%
Market Cap 384.97K
Revenue (ttm) 5.04M
Net Income (ttm) -7.06M
Shares Out 13.14M
EPS (ttm) -0.56
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,930
Average Volume 15,089
Open 0.0300
Previous Close 0.0293
Day's Range 0.0286 - 0.0300
52-Week Range 0.0231 - 0.0786
Beta 0.89
RSI 38.95
Earnings Date Apr 14, 2026

About RMTG

Regenerative Medical Technology Group Inc. operates in the regenerative medicine industry in the United States and internationally. It provides products, solutions, equipment, services, and training to doctors and their staff in the application of stem cell therapies. The company is also involved in the treatment of patients; provision of training and seminars; and resale of kits, products, equipment, and services. In addition, it offers reoccurring application of its process using its kits and solutions. The company was formerly known as Meso ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol RMTG
Full Company Profile

Financial Performance

In 2024, RMTG's revenue was $4.11 million, an increase of 70.44% compared to the previous year's $2.41 million. Losses were -$5.56 million, -43.31% less than in 2023.

Financial Statements

News

There is no news available yet.